X4 Pharmaceuticals (XFOR) Gross Margin (2024 - 2026)
X4 Pharmaceuticals' Gross Margin came in at 81.64% for Q2 2026, down 1.84 percentage points from 83.48% a year earlier but up 3.72 percentage points from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Gross Margin (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, X4 Pharmaceuticals reported Gross Margin of 81.51%, down 1.49 percentage points year-over-year; for FY2025, it came in at 83.60%, up 14.77 percentage points from FY2024.
- Going back by year, Gross Margin was 68.83% in FY2024.
- The five-year range for quarterly Gross Margin is 52.40% (Q2 2024) to 85.83% (Q4 2025).
- Year-over-year, Gross Margin increased in three of the last five quarters, with an average year-over-year change of +10.21 percentage points.
- Business Quant data shows XFOR's Gross Margin at 77.92% (Q1 2026), 85.83% (Q4 2025) and 80.11% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | X4 Pharmaceuticals | 381.56 Mn | -317.13 Mn | 7.19 Mn | 81.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.64% |
| Mar 31, 2026 | 77.92% |
| Dec 31, 2025 | 85.83% |
| Sep 30, 2025 | 80.11% |
| Jun 30, 2025 | 83.48% |
| Mar 31, 2025 | 83.63% |
| Dec 31, 2024 | 78.94% |
| Sep 30, 2024 | 59.46% |
| Jun 30, 2024 | 52.40% |
API Access
X4 Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();